PUBLISHER: IMARC | PRODUCT CODE: 1702138
PUBLISHER: IMARC | PRODUCT CODE: 1702138
The global magnetite nanoparticles market size reached USD 89.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 204.8 Million by 2033, exhibiting a growth rate (CAGR) of 9.11% during 2025-2033.
Magnetite nanoparticles (NPs) are structures composed of different metallic elements, such as iron, cobalt, nickel, and platinum, or metal alloys, which exhibit superparamagnetic properties at ambient temperatures. Their compact size and non-toxic properties make them viable for applications in catalysis, biosensors, ferrofluids, magnetic separations, and magnetic resonance imaging (MRI) contrast agents. Due to their high coercivity, low curie temperature, and excellent magnetic susceptibility, magnetite NPs have now become an important element in developing novel biomedical applications. They are consequently used in nanotoxicology and magnetic nanotechnology research and development (R&D) across the globe.
Magnetite NPs find extensive applications in cancer therapy, drug nanocarriers (NCs), targeted delivery systems, and diagnosis involving two guided NPs as nanoprobes and contrast agents. This, in confluence with the increasing prevalence of chronic diseases and the rising need for improved diagnostic modalities and personalized treatments, represents one of the key factors bolstering the market growth. Moreover, magnetic NPs are gaining traction in magnetic bio-separation and detection of biological entities, such as cells, proteins, nucleic acids, enzymes, bacteria, and viruses. Besides this, as the magnetic properties of magnetite NPS can efficiently remove contaminants from wastewater, they are considered suitable for wastewater treatment processes, including flocculation, demulsification, adsorption, filtration, and photocatalytic activities. In addition, rapidly diminishing freshwater resources and the growing wastewater complexities are driving the demand for magnetic NPs. Apart from this, researchers are focusing on obtaining functionalized magnetite NPs via green chemistry to reduce environmental pollution. Such developments are anticipated to aid the usage of magnetite NPs in various industrial applications and medical practices to improve the quality of life of the patients.
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Elements, Cytodiagnostics Inc., Merck KGaA, Nano Research Elements Inc., nanoComposix (Fortis Life Sciences), Nanografi Nano Technology, Nanoshel LLC, Reade International Corp., SkySpring Nanomaterials Inc., Strem Chemicals Inc. and US Research Nanomaterials Inc.